Identification of novel Pax8 targets in FRTL-5 thyroid cells by gene silencing and expression microarray analysis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Di Palma, Tina ^a   Conti, Anna ^b   de Cristofaro, Tiziana ^a   Scala, Serena ^a   Nitsch, Lucio ^b   Zannini, Mariastella ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTOME; PAIRED BOX TRANSCRIPTION FACTOR; PAX8 PROTEIN, RAT;

ANIMAL CELL; ANION TRANSPORT; APOPTOSIS; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA REPLICATION; GENE CONTROL; GENE EXPRESSION; GENE REPLICATION; GENE SILENCING; GENE TARGETING; MICROARRAY ANALYSIS; MORPHOGENESIS; MULTIGENE FAMILY; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; RAT; THYROID FOLLICLE CELL; ANIMAL; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; THYROID GLAND;

ANIMALS; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENE SILENCING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIRED BOX TRANSCRIPTION FACTORS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; THYROID GLAND;

EID: 80053103995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025162     Document Type: Article

References (57)

1. De Felice M, Di Lauro R, (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25: 722-746.
2. Puppin C, Presta I, D'Elia AV, Tell G, Arturi F, et al. (2004) Functional interaction among thyroid-specific transcription factors: Pax8 regulates the activity of Hex promoter. Mol Cell Endocrinol 214: 117-125.
3. Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, et al. (1990) Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development 110: 643-651.
4. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R, (1999) The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 19: 2051-2060.
5. Pasca di Magliano M, Di Lauro R, Zannini M, (2000) Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci U S A 97: 13144-13149.
6. Zannini M, Francis-Lang H, Plachov D, Di Lauro R, (1992) Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol Cell Biol 12: 4230-4241.
7. Mansouri A, Chowdhury K, Gruss P, (1998) Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19: 87-90.
8. Di Palma T, Nitsch R, Mascia A, Nitsch L, Di Lauro R, et al. (2003) The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription. J Biol Chem 278: 3395-3402.
9. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, et al. (2009) TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp Cell Res 315: 162-175.
10. Di Palma T, de Cristofaro T, D'Ambrosio C, Del Prete D, Scaloni A, et al. (2008) Poly(ADP-ribose) polymerase 1 binds to Pax8 and inhibits its transcriptional activity. J Mol Endocrinol 41: 379-388.
11. Di Palma T, Zampella E, Filippone MG, Macchia PE, Ris-Stalpers C, et al. (2010) Characterization of a novel loss-of-function mutation of PAX8 associated with congenital hypothyroidism. Clin Endocrinol (Oxf) 73: 808-814.
12. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, et al. (1998) PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 19: 83-86.
13. Chia WK, Sharifah NA, Reena RM, Zubaidah Z, Clarence-Ko CH, et al. (2010) Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms. Cancer Genet Cytogenet 196: 7-13.
14. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, et al. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87: 3947-3952.
15. Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, et al. (2007) Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 104: 331-337.
16. Chen YJ, Campbell HG, Wiles AK, Eccles MR, Reddel RR, et al. (2008) PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma. Cancer Res 68: 5724-5732.
17. Roider HG, Manke T, O'Keeffe S, Vingron M, Haas SA, (2009) PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics 25: 435-442.
18. D'Andrea B, Iacone R, Di Palma T, Nitsch R, Baratta MG, et al. (2006) Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction. Mol Endocrinol 20: 1810-1824.
19. Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, et al. (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 13: 64-75.
20. Braganca J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC, et al. (2003) Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 278: 16021-16029.
21. Tien ES, Davis JW, Vanden Heuvel JP, (2004) Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J Biol Chem 279: 24053-24063.
22. Gonzalez YR, Zhang Y, Behzadpoor D, Cregan S, Bamforth S, et al. (2008) CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage. J Neurosci 28: 5559-5569.
23. Wu ZZ, Sun NK, Chao CC, (2010) Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. J Cell Physiol.
24. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I, (2003) Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23: 1004-1013.
25. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, et al. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078.
26. Mahoney WM Jr, Hong JH, Yaffe MB, Farrance IK, (2005) The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 388: 217-225.
27. Murakami M, Nakagawa M, Olson EN, Nakagawa O, (2005) A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci U S A 102: 18034-18039.
28. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, et al. (2006) Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 339: 533-539.
29. Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, et al. (2004) TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem 279: 17384-17390.
30. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, et al. (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436.
31. de Cristofaro T, Di Palma T, Ferraro A, Corrado A, Lucci V, et al. (2011) TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur J Cancer 47: 926-933.
32. Endo T, Ohta K, Kobayashi T, (2008) Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells. J Clin Endocrinol Metab 93: 2409-2412.
33. Endo T, Kobayashi T, (2010) Runx2 deficiency in mice causes decreased thyroglobulin expression and hypothyroidism. Mol Endocrinol 24: 1267-1273.
34. Hegedus Z, Czibula A, Kiss-Toth E, (2006) Tribbles: novel regulators of cell function; evolutionary aspects. Cell Mol Life Sci 63: 1632-1641.
35. Bradshaw AD, Sage EH, (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054.
36. Lane TF, Sage EH, (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8: 163-173.
37. Mok SC, Chan WY, Wong KK, Muto MG, Berkowitz RS, (1996) SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene 12: 1895-1901.
38. Nishida Y, Yoshioka M, St-Amand J, (2005) The top 10 most abundant transcripts are sufficient to characterize the organs functional specificity: evidences from the cortex, hypothalamus and pituitary gland. Gene 344: 133-141.
39. Provenzano C, Pascucci B, Lupari E, Civitareale D, (2010) Large scale analysis of transcription factor TTF-1/NKX2.1 target genes in GnRH secreting cell line GT1-7. Mol Cell Endocrinol 323: 215-223.
40. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R, (1989) A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J 8: 2537-2542.
41. Damante G, Tell G, Di Lauro R, (2001) A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 66: 307-356.
42. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, et al. (2000) Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14: 650-654.
43. Stark K, Vainio S, Vassileva G, McMahon AP, (1994) Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679-683.
44. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP, (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405-409.
45. Torban E, Dziarmaga A, Iglesias D, Chu LL, Vassilieva T, et al. (2006) PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem 281: 12705-12712.
46. Narlis M, Grote D, Gaitan Y, Boualia SK, Bouchard M, (2007) Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol 18: 1121-1129.
47. Kikuchi A, Yamamoto H, (2008) Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 99: 202-208.
48. Miyakoshi T, Takei M, Kajiya H, Egashira N, Takekoshi S, et al. (2008) Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Endocr Pathol 19: 261-273.
49. Zacchi P, Stenmark H, Parton RG, Orioli D, Lim F, et al. (1998) Rab17 regulates membrane trafficking through apical recycling endosomes in polarized epithelial cells. J Cell Biol 140: 1039-1053.
50. D'Adamo MC, Shang L, Imbrici P, Brown SD, Pessia M, et al. (2011) Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity. J Biol Chem 286: 192-198.
51. Whyte DA, Li C, Thomson RB, Nix SL, Zanjani R, et al. (1999) Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity. Am J Physiol 277: F587-598.
52. Cali G, Zannini M, Rubini P, Tacchetti C, D'Andrea B, et al. (2007) Conditional inactivation of the E-cadherin gene in thyroid follicular cells affects gland development but does not impair junction formation. Endocrinology 148: 2737-2746.
53. Tepass U, Truong K, Godt D, Ikura M, Peifer M, (2000) Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 1: 91-100.
54. Ambesi-Impiombato FS, Coon HG, (1979) Thyroid cells in culture. Int Rev Cytol Suppl pp. 163-172.
55. Zhang B, Schmoyer D, Kirov S, Snoddy J, (2004) GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 5: 16.
56. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545.
57. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.